1-855-378-42281-855-378-4228
One of the outpatient treatment alternatives for people in East Winthrop who are battling with opioid dependence and addiction is called opioid maintenance therapy. Some centers and doctors are authorized to dispense specific medications to opioid dependent clients, many of which are opioid-based also and are addictive. With low amounts however, the individual does not experience being high but also doesn't experience intense cravings and isn't experiencing opioid withdrawal. Methadone is the first medication administered for this reason, but there are other choices to pick from.
Methadone is an opiate and can be taken at an outpatient clinic certified to dispense the med, that is taken on a daily basis in liquid or pill form. The price of the med is around $150 per month. Buprenorphine is also an opioid based med, and is in pill form often taken one day on, one day off. But unlike Methadone which can only be administered in highly well-regulated medical centers, Buprenorphine can be and is prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is around just under $300 /month for the generic version of the medication. There is also a type of buprenorphine containing the drug naloxone, which is a med which reverses the effects of opiates. Someone taking this version of the drug, AKA Suboxone, would find it harder to get high from opioids if they relapsed while taking the drug. It too is taken every day, and is priced approximately $450 a month. Naltrexone is an additional medication used in opioid maintenance therapy, but unlike the other medications mentioned it's an opioid blocker and isn't an opioid. A person has the choice to take this medication as a monthly shot, which is called Vivitrol. As an opioid blocker, the drug prevents a person from feeling high from opioids, and therefore lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 /month.
For All Alcohol and Drug Rehab Facilities In East Winthrop, Click Here.
